Recovery homes, regulation, & medication for opioid use disorder: preliminary look in a Southwestern state

This study examines the role of recovery homes in supporting individuals with substance use disorders and their transition to independent living. It highlights the challenges related to licensing, regulation, and stigma surrounding medication for opioid use disorder (MOUD) within recovery homes. A survey was conducted among recovery home affiliates in Arizona to assess their understanding of licensing requirements and attitudes toward MOUD. The results indicate a need for standardized regulations, increased acceptance of MOUD, and resources to meet licensing requirements. Favorable attitudes toward MOUD were associated with higher odds of having organizational resources to meet licensing requirements. These findings emphasize the importance of addressing stigma, promoting favorable attitudes, and ensuring quality care in recovery homes. Future research should explore barriers and facilitators to MOUD acceptance and implementation in recovery homes.